Related Experiment Video
Updated: Aug 14, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
LINC00926 is involved in hypoxia-induced vascular endothelial cell dysfunction via miR-3194-5p regulating JAK1/STAT3
Yong Jiang1, Chun-Hui Xu2, Ying Zhao3
1Department of Laboratory Medicine, Jilin Medical University, Jilin . jiangyongpost@sina.com.
Insights
Long noncoding RNA LINC00926 worsens endothelial cell dysfunction in coronary heart disease by regulating the miR-3194-5p/JAK1/STAT3 pathway under hypoxia.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- RNA Biology
Background:
- Vascular endothelial cell (VEC) dysfunction contributes to coronary heart disease (CHD).
- Long noncoding RNA (lncRNA) LINC00926 is dysregulated in CHD patients, but its role remains unclear.
- Understanding LINC00926's function in endothelial cells under stress is crucial.
Purpose of the Study:
- To investigate the regulatory mechanism of LINC00926 in human umbilical vein endothelial cells (HUVECs) exposed to hypoxia.
- To elucidate the role of LINC00926 in endothelial cell dysfunction.
Main Methods:
- Hypoxia exposure of HUVECs (5% O2 for 24 h).
- RT-qPCR and Western blotting for gene and protein expression.
- CCK-8, flow cytometry, Transwell, and angiogenesis assays for cell function.
- Bioinformatics and dual-luciferase reporter assays to confirm molecular interactions.
Main Results:
- LINC00926 expression was elevated in CHD patients and hypoxia-exposed HUVECs.
- Overexpression of LINC00926 impaired HUVEC proliferation, migration, and tube formation, while increasing apoptosis.
- LINC00926 targets miR-3194-5p, which in turn targets JAK1, modulating the JAK1/STAT3 pathway.
Conclusions:
- LINC00926 exacerbates endothelial cell dysfunction in hypoxia via the miR-3194-5p/JAK1/STAT3 signaling axis.
- This finding highlights LINC00926 as a potential therapeutic target for CHD-related endothelial dysfunction.
Abstract:
Vascular endothelial cell (VEC) dysfunction is associated with the development of coronary heart disease (CHD). Long intergenic non-protein coding RNA 926 (LINC00926), a kind of long noncoding RNA (lncRNA), has been found to be abnormally expressed in CHD patients. However, the biological role of LINC00926 has not been reported. In our research, we intended to explore the regulatory mechanism of LINC00926 in hypoxia-exposed HUVEC cells (HUVECs). In our in vitro study, HUVECs were exposed under hypoxic conditions (5% O2) for 24 h. RT-qPCR and Western blotting assay were used to detect the mRNA and protein levels. CCK-8 assay, flow cytometry, transwell assay and in vitro angiogenesis assay were performed to measure cell proliferation, apoptosis, migration and tube formation, respectively. Bioinformatics analysis was applied to predict the target of LINC00926 and miR-3194-5p, which was verified by dual-luciferase reporter assays. The results showed that LINC00926 was highly expressed in CHD patients and hypoxia-exposed HUVECs. LINC00926 overexpression suppressed cell proliferation, migration and tube formation and increased cell apoptosis. MiR-3194-5p was a target of LINC00926 and can target binding to JAK1 3'UTR. LINC00926 could up-regulate JAK1 and p-STAT3 levels via miR-3194-5p. In addition, overexpressed LINC00926 suppressed cell proliferation, migration and tube formation and increased cell apoptosis via miR-3194-5p/JAK1/STAT3 axis. In summary, LINC00926 aggravated endothelial cell dysfunction via miR-3194-5p regulating JAK1/STAT3 signaling pathway in hypoxia-exposed HUVECs.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway
Nitric Oxide Signaling Pathway
Mechanism of Angiogenesis
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

